
Stockhead's Tylah Tully speaks with @Neurizon_ltd executive chair Sergio Duchini about the latest developments surrounding NUZ-001, the company’s lead drug candidate targeting neurodegenerative diseases. buff.ly/0aIb7S2 #ASX
English
Stockhead
38.1K posts

@StockheadAU
Big discoveries, amazing science, hot technology: Stockhead publishes exclusive news about emerging ASX-listed companies.


















